Overview
Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
Status:
Unknown status
Unknown status
Trial end date:
2010-09-01
2010-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study aimed to assess the effectiveness and safety of L-ornithine-L-aspartate in the management of hepatic encephalopathy.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hospital de Clinicas de Porto AlegreTreatments:
N-Methylaspartate
Criteria
Inclusion Criteria:- Cirrhosis and diagnosis of minimal hepatic encephalopathy using psychometric tests and
critical flicker frequency
Exclusion Criteria:
- Hepatic encephalopathy grade 1 to 4
- Use of drugs to treatment of hepatic encephalopathy (lactulose, neomycin)
- Psychoactive substance use within 72 hours